Drugs Made In America Acquisition II Corp. Unit

Drugs Made In America Acquisition II Corp. Unit

DMIIU - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$512.5M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Drugs Made In America Acquisition II Corp. UnitDrugs Made In America Acquisition II Corp. Unit33.8-4%--

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$512.50 Million
Enterprise Value$512.83 Million
Earnings per Share$0.16
Beta0.06
Outstanding Shares50,000,000

Return

Return on Equity3.53%ROE
Return on Assets3.41%
Return on Invested Capital-0.26%

Valuation & Multiples

P/E Ratio33.8P/E Ratio
PEG-0.33PEG
Price to Sales-Price to Sales
Price to Book Ratio1.03Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-374.64
Enterprise Value to Net Income29
Total Debt to Enterprise0
Debt to Equity0Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Drugs Made In America Acquisition II Corp. Ordinary Shares

2 employees
CEO: Roger Bendelac

Drugs Made In America Acquisition II Corp. currently lacks significant business operations. Its core objective is to execute a business combination, which may take various forms such as a merger, an acquisition of assets or shares, a rec...